Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty indicated no significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:
José-Manuel Carrascosa Carrillo
Antonio Costanzo
Torello Lotti
Ketty Peris
Terence Wilkin
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:
Christina Antoniou - Declared that her presentation will include discussion of off-labelled or non-approved use of biologicals in dermatology.
Bernd Bonnekoh - Declared receipt of a limited-value grant from Merck Serono for partial support of a clinical experimental study.
Enno Christophers - Declared to be a Member of Wyeth Scientific Advisory Board.
John M. Cruickshank - Declared receipt of honoraria or consultation fees from Merck Serono.
Peter Foley - Declared receipt of honoraria or consultation fees from Merck Serono, Schering-Plough, Wyeth and to participate in Merck Serono, Schering-Plough and Wyeth speakers’ bureau.
Christopher E.M. Griffiths - Declared receipt of grants and contracts from Merck Serono, Wyeth, Centocor and to receive honoraria or consultation fees, as well as being a member of the advisory boards, board of directors or other similar groups, from Merck Serono, Wyeth, Abbott, Schering- Plough, Centocor, UCB Pharma, Pfizer.
Wayne P. Gulliver - Declared to be a to be a member of Amevive Advisory Board (Astellas), Decision Aid Steering Committee (Ortho Biotech) and to conduct clinical trials for the following commercial enterprises: 3M Pharmaceuticals Division, Abbott Laboratories, Advanced Immuni T, Allergan, Amgen, Apollo Pharmaceuticals, Astellas Pharmaceuticals, AstraZeneca, Atrix, Aventis, Barrier Therapeutics, Basilea, Berlex Laboratories Inc., Biogen, Centocor, Dermacor, Dimethaid Health Care Ltd., Fujisawa, Galderma, Genentech Inc., Genmab, GlaxoSmithKline, Global Pharmaceuticals, Hoffmann-La Roche, Isotechnika, Janssen–Ortho Inc., Jerini, Kadmus Pharmaceuticals Ltd., Leo Pharma, Novartis, Pfizer Inc.,Prime Pharmaceuticals, Protein Design Labs, Schering, EMD Serono, Stiefel Canada Inc., Wyeth.
Andreas Katsambas - Declared receipt of honoraria or consultation fees from Wyeth, Schering-Plough, Leo and to be a member of Wyeth, Schering-Plough advisory board, board of directors or other similar group.
Morad Lahfa - Declared receipt of honoraria or consultation fees from Merck Serono France.
Rotraut Mössner - Declared receipt of grants and contracts from Abbott, Essex and receipt of honoraria or consultation fees from Biogen Idec.
Kim Papp - Declared receipt of grants and contracts from Abbott, Abbott Canada, Allergan, Alza, Amgen, Amgen Canada, Boehringer Ingelheim, Celgene, Centocor, Genentech, Isotechnika, Leo Consultant, Medimmune, Merck Serono. Declared receipt of honoraria or consultation fees from the above mentioned companies and from 3M, Astellas, Biogen, Genexion, Janssen-Ortho, J&J Pharmaceutical Services, NovImmune and Ortho Biotech and to be member of the following companies’ speakers bureau: 3M, Allergan, Allergan Canada, Amgen, Amgen Canada, Astellas, Berlex, Biogen, Fujisawa, Genentech, GSK, Istotechnika, Janssen-Ortho, Leo Canada, Medimmune, Merck Serono, Merck Serono Canada, Novartis Canada, Roche, Schering-Plough, Schering-Plough Canada, Stiefel, Wyeth, Wyeth Canada.
Peter Passmore - Declared receipt of grants and contracts, clinical trial support and travel grants from Pfizer. Prof. Passmore also disclosed that his presentation includes the use of off-labelled or otherwise non-approved use of atorvastatin in Alzheimer’s disease.
Luis Puig - Declared receipt of grants and contracts for clinical trials from Merck Serono, Wyeth, Schering Plough, Abbott and receipt of honoraria or consultation fees from Merck Serono, Wyeth, Schering-Plough. He also declared to be a member of company advisory boards, board of directors or similar groups and to participate in the following companies’ speakers’ bureau: Merck Serono, Wyeth, Schering Plough.
Diamant Thaci - Declared to receive honorarie or consultation fees from Serono, Abbott, Almiral, Hermal, Leo, Wyeth, Essex, Novartis, Biogen-Idec, Cellgene. Declared to be member of the following company advisory board, board of directors or other similar group: Schering-Plough, Essex, Wyeth, Biogen-Idec, Leo, Novartis and to participate in the following companies’ sponsored speakers’ bureau: Schering-Plough, Essex, Leo Novartis.
Friedhelm Späh - Declared receipt of honoraria or consultation fees from Bayer, Merck Serono, Sanofi -Aventis and to be a member of Takeda advisory board, board of directors or other similar group.
Alexander J. Stratigos - Declared receipt of grants and contracts from Merck Serono, Wyeth and receipt of honoraria or consultation fees from Merck Serono.
Ronald Vender - Declared to participate in the following company sponsored speakers’ bureaux: Abbott, EMD Serono, Schering-Plough, Centocor, Astellas, Amgen.
Gottfried Wozel - Declared receipt of grants and contracts for clinical trials with biologicals and to be a member of the following companies’ advisory boards, board of directors or similar groups: Abbott, Astellas, Biogen Idec., Centocor, Essex, Leo, Wyeth. Prof. Wozel also declared to participate in Centocor Speaker’s bureau.
